Young Investigator Award

• Applicants must be post-doctoral fellows, within 3 years after receipt of their first doctoral degree, with an appointment at an accredited university or research institution (exceptional pre-doctoral students pursuing qualified projects may also apply)
• Applicants applying must have an MD, PhD, or equivalent advanced degree, and hold a position within the laboratory of a senior researcher or principal investigator who will serve as the applicant’s mentor**
• Applications from individuals holding faculty positions will not be accepted
• There are no citizenship requirements for this program; Adaptive Biotechnologies welcomes applications from all qualified individuals from qualifying institutions worldwide

** It is expected that all applicants will write their application independently, with only limited assistance from their mentor

• Research proposals may focus on any aspect of immunology or related fields with potential implications towards advancement in immunology
• Proposals must describe a pilot study to profile either the human or mouse TCR or BCR repertoire
• Proposal length is limited to one page
• Proposals must be for research purposes only; Adaptive Biotechnologies does not currently offer public grants for clinical research projects (e.g. diagnostic or therapeutic trials)

Proposals will be evaluated on: the innovative application of immunoSEQ Assays to the research concept, the soundness of the research design, and the value of the research to the field of immunology.

• Winners receive a $10,000 grant for use towards the purchase of any immunoSEQ Assay immune cell sequencing Service
• Winners agree to cite Adaptive Biotechnologies in the methods section of any resulting publication
• Winners also agree to be interviewed for, and possibly highlighted in, Adaptive’s Researcher Profiles feature (with potential distribution via various promotional and media channels)
• Winners must agree to submit data generated from their project to the immuneACCESS database within six months after its public release (i.e. any public reference to the data including, but not limited to, presentation via abstract, poster, or speaking engagement, press release, media interview, etc.)
• Grant funds expire one year from date of award

All grant determinations and interpretations of the Young Investigator Award program will be made in the sole and absolute discretion of Adaptive Biotechnologies Corporation. The grant program may be revoked or terminated at any time for any reason, even after a grant notification has been issued. Winners will be required to sign or acknowledge a written grant agreement with Adaptive Biotechnologies Corporation as a condition for using the granted services.

You may not be eligible to receive the grant if you work for an institution that purchases diagnostic services from Adaptive Biotechnologies or if offering you the grant is otherwise prohibited under applicable law, which determination will be made by Adaptive Biotechnologies in its sole and absolute discretion. This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments website. More information about the Sunshine Act and CMS Open Payments program can be found here.